MIRAGE syndrome

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

3 events
Jul 2022Gut Microbiota Analysis in Patients Undergoing Duodencephalopancreasectomy for Pancreatic Cancer

IRCCS Azienda Ospedaliero-Universitaria di Bologna — NA

TrialRECRUITING
May 2020CT-guided Stereotactic Body Radiation Therapy and MRI-guided Stereotactic Body Radiation Therapy for Prostate Cancer, MIRAGE Study

Jonsson Comprehensive Cancer Center

TrialACTIVE NOT RECRUITING
Apr 2017

Alunbrig: FDA approved

Treatment of patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for MIRAGE syndrome.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

Alunbrig

(brigatinib)Orphan drug

Takeda Development Center Americas, Inc.

Kinase Inhibitor [EPC]

12.1 Mechanism of Action Brigatinib is a tyrosine kinase inhibitor (TKI) with in vitro activity at clinically achievable concentrations against multip...

Approved Apr 2017FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for MIRAGE syndrome.
Search all trials →
Search clinical trials for MIRAGE syndrome

Recent News & Research

No recent news articles indexed yet for MIRAGE syndrome.
Search PubMed for MIRAGE syndrome

Browse all MIRAGE syndrome news →

Specialist Network

Top 6 by expertise

View all MIRAGE syndrome specialists →

Quick Actions